TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,882
|
2,806
|
2,595 |
Financial expenses |
1
|
3
|
0 |
Earnings before taxes |
155
|
516
|
724 |
EBITDA |
188
|
519
|
668 |
Total assets |
2,155
|
1,448
|
1,415 |
Current assets |
1,753
|
1,267
|
300 |
Current liabilities |
757
|
241
|
331 |
Equity capital |
1,398
|
1,207
|
1,084 |
- share capital |
101
|
95
|
98 |
Employees (average) |
3
![]() |
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
64.9%
|
83.4%
|
76.6% |
Turnover per employee |
961
|
935
|
1,298 |
Profit as a percentage of turnover |
5.4%
|
18.4%
|
27.9% |
Return on assets (ROA) |
7.2%
|
35.8%
|
51.2% |
Current ratio |
231.6%
|
525.7%
|
90.6% |
Return on equity (ROE) |
11.1%
|
42.8%
|
66.8% |
Change turnover |
-123
|
289
|
136 |
Change turnover % |
-4%
|
11%
|
6% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.